GlassScriptPhysician profile
Phoebe C Tam
NPI 1326136227
$6,181.97
in general payments reported to CMS, 2019-2025
21 companies · $1,406 in 2025
The $1,406 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $842 · 2022: $960 · 2023: $1,432 · 2024: $1,542 · 2025: $1,406.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,001 · Education: $379.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,001.42 |
| Education | $378.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $889.57 | 2021-2025 | Tremfya, Simponi, Stelara |
| Abbvie INC. | $852.44 | 2021-2025 | |
| Leo Pharma INC. | $767.91 | 2022-2025 | Adbry, Anzupgo |
| Arcutis Biotherapeutics, INC. | $467.08 | 2023-2025 | Zoryve |
| Revance Therapeutics, INC. | $452.42 | 2024 | Daxxify |
| Dermavant Sciences, INC. | $383.49 | 2023-2024 | Vtama |
| Incyte Corporation | $363.28 | 2021-2025 | Opzelura |
| E.R. Squibb & Sons, L.L.C. | $295.78 | 2022-2025 | Sotyktu |
| Amgen INC. | $289.13 | 2021-2024 | Otezla, Lumakras |
| Novartis Pharmaceuticals Corporation | $280.66 | 2021-2024 | |
| Pfizer INC. | $245.11 | 2022-2025 | |
| Galderma Laboratories, L.P. | $228.53 | 2021-2022 | |
| Lilly USA, LLC | $202.46 | 2022-2023 | Olumiant, Taltz |
| Genzyme Corporation | $144.04 | 2021-2024 | |
| Mayne Pharma Commercial LLC | $114.55 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $99.00 | 2021 | |
| Organon LLC | $27.08 | 2025 | Vtama |
| Sun Pharmaceutical Industries INC. | $25.93 | 2025 | |
| Almirall LLC | $23.24 | 2023 | Klisyri |
| Dermira, INC. | $16.62 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $13.65 | 2025 | Cabtreo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phoebe Tam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.